BG35328A3 - Method for preparing imidodisulphamidic derivatives - Google Patents

Method for preparing imidodisulphamidic derivatives

Info

Publication number
BG35328A3
BG35328A3 BG051608A BG5160881A BG35328A3 BG 35328 A3 BG35328 A3 BG 35328A3 BG 051608 A BG051608 A BG 051608A BG 5160881 A BG5160881 A BG 5160881A BG 35328 A3 BG35328 A3 BG 35328A3
Authority
BG
Bulgaria
Prior art keywords
preparing
derivatives
imidodisulphamidic
proven
formulated
Prior art date
Application number
BG051608A
Other languages
Bulgarian (bg)
English (en)
Inventor
Fadia Ali
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG35328A3 publication Critical patent/BG35328A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG051608A 1980-04-14 1981-04-10 Method for preparing imidodisulphamidic derivatives BG35328A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14002180A 1980-04-14 1980-04-14
US06/159,340 US4315935A (en) 1980-04-14 1980-06-13 N,N'-Bis[substituted-1,2,3,4-tetrahydroisoquinolinolyl]disulfonylimides and antiallergic compositions and method of use

Publications (1)

Publication Number Publication Date
BG35328A3 true BG35328A3 (en) 1984-03-15

Family

ID=26837794

Family Applications (1)

Application Number Title Priority Date Filing Date
BG051608A BG35328A3 (en) 1980-04-14 1981-04-10 Method for preparing imidodisulphamidic derivatives

Country Status (25)

Country Link
US (1) US4315935A (OSRAM)
EP (1) EP0038177B1 (OSRAM)
KR (1) KR850000272B1 (OSRAM)
AR (1) AR229160A1 (OSRAM)
AU (1) AU536754B2 (OSRAM)
BG (1) BG35328A3 (OSRAM)
CA (1) CA1162545A (OSRAM)
CS (1) CS222695B2 (OSRAM)
DD (1) DD158240A5 (OSRAM)
DE (1) DE3160805D1 (OSRAM)
DK (1) DK149846C (OSRAM)
ES (1) ES8207145A1 (OSRAM)
FI (1) FI74702C (OSRAM)
GR (1) GR75217B (OSRAM)
IE (1) IE51220B1 (OSRAM)
IL (1) IL62631A (OSRAM)
MX (1) MX6697E (OSRAM)
NO (1) NO811278L (OSRAM)
NZ (1) NZ196773A (OSRAM)
PL (1) PL125404B1 (OSRAM)
PT (1) PT72828B (OSRAM)
RO (1) RO81944A (OSRAM)
SU (1) SU1017169A3 (OSRAM)
YU (1) YU98081A (OSRAM)
ZW (1) ZW8381A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
US4385047A (en) * 1981-01-05 1983-05-24 Smithkline Beckman Corporation Antiallergic imidodisulfamides
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
US4350698A (en) * 1981-09-25 1982-09-21 Smithkline Corporation Antiallergic imidosulfamides
US4536510A (en) * 1983-07-22 1985-08-20 Smith Kline Beckman Corporation Method of antagonizing the effects of thromboxane
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
CA2408913A1 (en) 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Melanin-concentrating hormone antagonist
JP2009504790A (ja) * 2005-08-22 2009-02-05 トランスファート プラス エスイーシー スルホニルイミド及びその誘導体を調製するための方法
JP5630048B2 (ja) 2009-03-31 2014-11-26 セントラル硝子株式会社 イミド酸化合物の製造方法
JP5471045B2 (ja) 2009-06-03 2014-04-16 セントラル硝子株式会社 イミド酸塩の製造方法
AR080374A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida
TW201300358A (zh) 2011-03-14 2013-01-01 大正製藥股份有限公司 含氮縮合雜環化合物
CN103524387A (zh) * 2013-10-25 2014-01-22 中国海洋石油总公司 一种双氟磺酰亚胺锂盐的制备方法
CN109721037B (zh) 2019-03-11 2019-12-24 上海如鲲新材料有限公司 一种双氟磺酰亚胺盐的新工艺
CN115010102B (zh) * 2022-06-29 2024-01-26 山东凯盛新材料股份有限公司 一种双氟磺酰亚胺的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
AT352135B (de) * 1975-07-30 1979-09-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer homophthalimide und ihrer salze
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
US4252818A (en) * 1979-08-02 1981-02-24 Merck & Co., Inc. Novel benzopyran derivatives

Also Published As

Publication number Publication date
AU536754B2 (en) 1984-05-24
IL62631A (en) 1984-05-31
ES501195A0 (es) 1982-09-01
KR830005148A (ko) 1983-08-03
GR75217B (OSRAM) 1984-07-13
NO811278L (no) 1981-10-15
US4315935A (en) 1982-02-16
AR229160A1 (es) 1983-06-30
KR850000272B1 (ko) 1985-03-15
RO81944A (ro) 1983-06-01
DK160681A (da) 1981-10-15
DK149846C (da) 1987-06-29
DE3160805D1 (en) 1983-10-06
FI811082L (fi) 1981-10-15
DK149846B (da) 1986-10-13
IE51220B1 (en) 1986-11-12
FI74702C (fi) 1988-03-10
MX6697E (es) 1985-10-21
PL230622A1 (OSRAM) 1981-12-23
CS222695B2 (en) 1983-07-29
ES8207145A1 (es) 1982-09-01
ZW8381A1 (en) 1981-07-08
PT72828B (en) 1982-03-30
PT72828A (en) 1981-05-01
DD158240A5 (de) 1983-01-05
SU1017169A3 (ru) 1983-05-07
AU6920081A (en) 1981-10-22
FI74702B (fi) 1987-11-30
CA1162545A (en) 1984-02-21
NZ196773A (en) 1983-07-15
IE810829L (en) 1981-10-14
EP0038177B1 (en) 1983-08-31
RO81944B (ro) 1983-05-30
YU98081A (en) 1983-10-31
PL125404B1 (en) 1983-05-31
EP0038177A1 (en) 1981-10-21

Similar Documents

Publication Publication Date Title
BG31496A3 (bg) Метод за получаване на 4-амино-5-алкил-сулфонил ортоанизамиди
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
BG38333A3 (bg) Метод за получаване на заместени фенилкарбоксиоксими
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG33886A3 (en) Method for heterocyclic compounds producing
BG33294A3 (bg) Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG35327A3 (bg) Метод за получаване на пиридоксинови производни
BG37993A3 (bg) Метод за получаване на 4-хинолонови производни
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG35330A3 (bg) Метод за получаване на 3-йодметилцефалоспорини
BG38163A3 (bg) Метод за получаване на пиримидони
BG34907A3 (en) Method for preparing benzodiazepine compounds
BG31498A3 (en) Method for obtaining of pyridiliminomethyl benzene derivatives
BG37992A3 (bg) Метод за получаване на производни на бензамида
BG37525A3 (en) Method for preparing n- substituted flavon- 8- carbonamides
BG38638A3 (bg) Метод за получаване на арилциклобутил-аминопроизводни
BG35464A3 (en) Method preparing fluorene derivatives
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG36495A3 (bg) Метод за получаване на 4-хинолови производни
BG35897A3 (bg) Метод за получаване на 5-(дихидрокси-фенокси)-1н-тетразоли
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони